as used in this `` management 's discussion and analysis of financial condition and results of operation , `` except where the context otherwise requires , the term `` we , `` `` us , `` `` our , `` or `` tiger x , `` refers to the business of tiger x medical , inc. overview tiger x medical , inc. ( `` tiger x `` or the `` company `` ) , formerly known as cardo medical , inc. , previously operated as an orthopedic medical device company specializing in designing , developing and marketing high performance reconstructive joint devices and spinal surgical devices . as discussed below , in 2011 we entered into an asset purchase agreement to sell substantially all of our assets in the reconstructive division to arthrex , inc. ( `` arthrex `` ) . additionally , we completed the sale of substantially all of the assets in the spine division in 2011. our continuing operations include the collection and management of our royalty income earned in connection with the asset purchase agreement with arthrex , as well as continuing to promote our former products sold to arthrex through participation in mobile teaching labs , seminars and live surgery and seek a joint venture partner or buyer for the remaining intellectual property owned by the company . the company will also be evaluating future investment opportunities and uses for its cash . we are headquartered in los angeles , california . our common stock is quoted on the national association of securities dealers , inc. 's , over-the-counter bulletin board , or the otc bulletin board with a trading symbol of cdom.ob . critical accounting policies and estimates our significant accounting policies are more fully described in the notes to our consolidated financial statements . those material accounting estimates that we believe are the most critical to an investor 's understanding of our financial results and condition are discussed immediately below and are particularly important to the portrayal of our financial position and results of operations and require the application of significant judgment by our management to determine the appropriate assumptions to be used in the determination of certain estimates . use of estimates financial statements prepared in accordance with united states generally accepted accounting principles ( `` u.s. gaap `` ) require management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period . among other things , management makes estimates relating to allowances for doubtful accounts , net realizable value of assets , share- based payment , and deferred income tax assets . actual results could differ from those estimates . 11 revenue recognition the company 's revenue consists of royalty income from arthrex pursuant to the arthrex asset purchase agreement . royalty income is recognized as the amount becomes known and collectability is reasonably assured . income taxes deferred income tax assets and liabilities are recognized to reflect the estimated future tax effects , calculated at currently effective tax rates , of future deductible or taxable amounts attributable to events that have been recognized on a cumulative basis in the financial statements . a valuation allowance related to a deferred income tax asset is recorded when it is more likely than not that some portion of the deferred income tax asset will not be realized . deferred income tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates on the date of enactment . the company recognizes all material tax positions , including all significant uncertain tax positions , in which it is more likely than not that the position will be sustained based on its technical merits and if challenged by the relevant taxing authorities . at each balance sheet date , unresolved uncertain tax positions are reassessed to determine whether subsequent developments require a change in the amount of recognized tax benefit . recent accounting pronouncements in may 2014 , the financial accounting standards board ( `` fasb `` ) issued accounting standards update ( `` asu `` ) 2014-09 , revenue from contracts with customers ( topic 606 ) . asu 2014-09 creates a new topic in the asc topic 606 and establishes a new control-based revenue recognition model , changes the basis for deciding when revenue is recognized over time or at a point in time , provides new and more detailed guidance on specific topics , and expands and improves disclosures about revenue . in addition , asu 2014-09 adds a new subtopic to the codification , asc 340-40 , other assets and deferred costs : contracts with customers , to provide guidance on costs related to obtaining a contract with a customer and costs incurred in fulfilling a contract with a customer that are not in the scope of another asc topic . the guidance in asu 2014-09 is effective for public entities for annual reporting periods beginning after december 15 , 2016 , including interim periods therein . early application is not permitted . management is in the process of assessing the impact of asu 2014-09 on the company 's financial statements . results of operations and financial condition for the year ended december 31 , 2015 as compared to the year ended december 31 , 2014 the following are the consolidated results of our operations for the year ended december 31 , 2015 compared to the year ended december 31 , 2014. replace_table_token_2_th 12 royalty income royalty income amounted to $ 517,000 for the year ended december 31 , 2015 compared with $ 427,000 for 2014. revenues represented royalties received from arthrex in connection with the arthrex asset purchase agreement . the increase during 2015 is the result of arthrex 's increased sales of the acquired product line . until we find a joint venture partner or buyer for our remaining intellectual property story_separator_special_tag as used in this `` management 's discussion and analysis of financial condition and results of operation , `` except where the context otherwise requires , the term `` we , `` `` us , `` `` our , `` or `` tiger x , `` refers to the business of tiger x medical , inc. overview tiger x medical , inc. ( `` tiger x `` or the `` company `` ) , formerly known as cardo medical , inc. , previously operated as an orthopedic medical device company specializing in designing , developing and marketing high performance reconstructive joint devices and spinal surgical devices . as discussed below , in 2011 we entered into an asset purchase agreement to sell substantially all of our assets in the reconstructive division to arthrex , inc. ( `` arthrex `` ) . additionally , we completed the sale of substantially all of the assets in the spine division in 2011. our continuing operations include the collection and management of our royalty income earned in connection with the asset purchase agreement with arthrex , as well as continuing to promote our former products sold to arthrex through participation in mobile teaching labs , seminars and live surgery and seek a joint venture partner or buyer for the remaining intellectual property owned by the company . the company will also be evaluating future investment opportunities and uses for its cash . we are headquartered in los angeles , california . our common stock is quoted on the national association of securities dealers , inc. 's , over-the-counter bulletin board , or the otc bulletin board with a trading symbol of cdom.ob . critical accounting policies and estimates our significant accounting policies are more fully described in the notes to our consolidated financial statements . those material accounting estimates that we believe are the most critical to an investor 's understanding of our financial results and condition are discussed immediately below and are particularly important to the portrayal of our financial position and results of operations and require the application of significant judgment by our management to determine the appropriate assumptions to be used in the determination of certain estimates . use of estimates financial statements prepared in accordance with united states generally accepted accounting principles ( `` u.s. gaap `` ) require management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period . among other things , management makes estimates relating to allowances for doubtful accounts , net realizable value of assets , share- based payment , and deferred income tax assets . actual results could differ from those estimates . 11 revenue recognition the company 's revenue consists of royalty income from arthrex pursuant to the arthrex asset purchase agreement . royalty income is recognized as the amount becomes known and collectability is reasonably assured . income taxes deferred income tax assets and liabilities are recognized to reflect the estimated future tax effects , calculated at currently effective tax rates , of future deductible or taxable amounts attributable to events that have been recognized on a cumulative basis in the financial statements . a valuation allowance related to a deferred income tax asset is recorded when it is more likely than not that some portion of the deferred income tax asset will not be realized . deferred income tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates on the date of enactment . the company recognizes all material tax positions , including all significant uncertain tax positions , in which it is more likely than not that the position will be sustained based on its technical merits and if challenged by the relevant taxing authorities . at each balance sheet date , unresolved uncertain tax positions are reassessed to determine whether subsequent developments require a change in the amount of recognized tax benefit . recent accounting pronouncements in may 2014 , the financial accounting standards board ( `` fasb `` ) issued accounting standards update ( `` asu `` ) 2014-09 , revenue from contracts with customers ( topic 606 ) . asu 2014-09 creates a new topic in the asc topic 606 and establishes a new control-based revenue recognition model , changes the basis for deciding when revenue is recognized over time or at a point in time , provides new and more detailed guidance on specific topics , and expands and improves disclosures about revenue . in addition , asu 2014-09 adds a new subtopic to the codification , asc 340-40 , other assets and deferred costs : contracts with customers , to provide guidance on costs related to obtaining a contract with a customer and costs incurred in fulfilling a contract with a customer that are not in the scope of another asc topic . the guidance in asu 2014-09 is effective for public entities for annual reporting periods beginning after december 15 , 2016 , including interim periods therein . early application is not permitted . management is in the process of assessing the impact of asu 2014-09 on the company 's financial statements . results of operations and financial condition for the year ended december 31 , 2015 as compared to the year ended december 31 , 2014 the following are the consolidated results of our operations for the year ended december 31 , 2015 compared to the year ended december 31 , 2014. replace_table_token_2_th 12 royalty income royalty income amounted to $ 517,000 for the year ended december 31 , 2015 compared with $ 427,000 for 2014. revenues represented royalties received from arthrex in connection with the arthrex asset purchase agreement . the increase during 2015 is the result of arthrex 's increased sales of the acquired product line . until we find a joint venture partner or buyer for our remaining intellectual property

liquidity and capital resources net cash provided by operating activities was $ 331,000 for the year ended december 31 , 2015 compared to net cash provided by operating activities of $ 214,000 for 2014. our cash provided by operations improved during 2015 primarily due to our royalty revenue increasing by $ 90,000 as compared to 2014. we had no cash flows from investing or financing activities during the year ended december 31 , 2015 or 2014. we believe our cash balances of $ 13,840,000 as of december 31 , 2015 are adequate to meet our cash needs for the next twelve months and beyond . off-balance sheet arrangements we have no off-balance sheet financing arrangements . contractual obligations we currently have no contractual obligations . forward looking statements our business , financial condition , results of operations , cash flows and prospects , and the prevailing market price and performance of our common stock , may be adversely affected by a number of factors , including the matters discussed in `` risk factors '' . certain statements and informationset forth in this annual report on form 10-k , as well as other written or oral statements made from time to time by us or by our authorized executive officers on our behalf , constitute `` forward-looking statements . ''


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```liquidity and capital resources net cash provided by operating activities was $ 331,000 for the year ended december 31 , 2015 compared to net cash provided by operating activities of $ 214,000 for 2014. our cash provided by operations improved during 2015 primarily due to our royalty revenue increasing by $ 90,000 as compared to 2014. we had no cash flows from investing or financing activities during the year ended december 31 , 2015 or 2014. we believe our cash balances of $ 13,840,000 as of december 31 , 2015 are adequate to meet our cash needs for the next twelve months and beyond . off-balance sheet arrangements we have no off-balance sheet financing arrangements . contractual obligations we currently have no contractual obligations . forward looking statements our business , financial condition , results of operations , cash flows and prospects , and the prevailing market price and performance of our common stock , may be adversely affected by a number of factors , including the matters discussed in `` risk factors '' . certain statements and informationset forth in this annual report on form 10-k , as well as other written or oral statements made from time to time by us or by our authorized executive officers on our behalf , constitute `` forward-looking statements . ''
```    
 Suspicious Activity Report : as used in this `` management 's discussion and analysis of financial condition and results of operation , `` except where the context otherwise requires , the term `` we , `` `` us , `` `` our , `` or `` tiger x , `` refers to the business of tiger x medical , inc. overview tiger x medical , inc. ( `` tiger x `` or the `` company `` ) , formerly known as cardo medical , inc. , previously operated as an orthopedic medical device company specializing in designing , developing and marketing high performance reconstructive joint devices and spinal surgical devices . as discussed below , in 2011 we entered into an asset purchase agreement to sell substantially all of our assets in the reconstructive division to arthrex , inc. ( `` arthrex `` ) . additionally , we completed the sale of substantially all of the assets in the spine division in 2011. our continuing operations include the collection and management of our royalty income earned in connection with the asset purchase agreement with arthrex , as well as continuing to promote our former products sold to arthrex through participation in mobile teaching labs , seminars and live surgery and seek a joint venture partner or buyer for the remaining intellectual property owned by the company . the company will also be evaluating future investment opportunities and uses for its cash . we are headquartered in los angeles , california . our common stock is quoted on the national association of securities dealers , inc. 's , over-the-counter bulletin board , or the otc bulletin board with a trading symbol of cdom.ob . critical accounting policies and estimates our significant accounting policies are more fully described in the notes to our consolidated financial statements . those material accounting estimates that we believe are the most critical to an investor 's understanding of our financial results and condition are discussed immediately below and are particularly important to the portrayal of our financial position and results of operations and require the application of significant judgment by our management to determine the appropriate assumptions to be used in the determination of certain estimates . use of estimates financial statements prepared in accordance with united states generally accepted accounting principles ( `` u.s. gaap `` ) require management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period . among other things , management makes estimates relating to allowances for doubtful accounts , net realizable value of assets , share- based payment , and deferred income tax assets . actual results could differ from those estimates . 11 revenue recognition the company 's revenue consists of royalty income from arthrex pursuant to the arthrex asset purchase agreement . royalty income is recognized as the amount becomes known and collectability is reasonably assured . income taxes deferred income tax assets and liabilities are recognized to reflect the estimated future tax effects , calculated at currently effective tax rates , of future deductible or taxable amounts attributable to events that have been recognized on a cumulative basis in the financial statements . a valuation allowance related to a deferred income tax asset is recorded when it is more likely than not that some portion of the deferred income tax asset will not be realized . deferred income tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates on the date of enactment . the company recognizes all material tax positions , including all significant uncertain tax positions , in which it is more likely than not that the position will be sustained based on its technical merits and if challenged by the relevant taxing authorities . at each balance sheet date , unresolved uncertain tax positions are reassessed to determine whether subsequent developments require a change in the amount of recognized tax benefit . recent accounting pronouncements in may 2014 , the financial accounting standards board ( `` fasb `` ) issued accounting standards update ( `` asu `` ) 2014-09 , revenue from contracts with customers ( topic 606 ) . asu 2014-09 creates a new topic in the asc topic 606 and establishes a new control-based revenue recognition model , changes the basis for deciding when revenue is recognized over time or at a point in time , provides new and more detailed guidance on specific topics , and expands and improves disclosures about revenue . in addition , asu 2014-09 adds a new subtopic to the codification , asc 340-40 , other assets and deferred costs : contracts with customers , to provide guidance on costs related to obtaining a contract with a customer and costs incurred in fulfilling a contract with a customer that are not in the scope of another asc topic . the guidance in asu 2014-09 is effective for public entities for annual reporting periods beginning after december 15 , 2016 , including interim periods therein . early application is not permitted . management is in the process of assessing the impact of asu 2014-09 on the company 's financial statements . results of operations and financial condition for the year ended december 31 , 2015 as compared to the year ended december 31 , 2014 the following are the consolidated results of our operations for the year ended december 31 , 2015 compared to the year ended december 31 , 2014. replace_table_token_2_th 12 royalty income royalty income amounted to $ 517,000 for the year ended december 31 , 2015 compared with $ 427,000 for 2014. revenues represented royalties received from arthrex in connection with the arthrex asset purchase agreement . the increase during 2015 is the result of arthrex 's increased sales of the acquired product line . until we find a joint venture partner or buyer for our remaining intellectual property story_separator_special_tag as used in this `` management 's discussion and analysis of financial condition and results of operation , `` except where the context otherwise requires , the term `` we , `` `` us , `` `` our , `` or `` tiger x , `` refers to the business of tiger x medical , inc. overview tiger x medical , inc. ( `` tiger x `` or the `` company `` ) , formerly known as cardo medical , inc. , previously operated as an orthopedic medical device company specializing in designing , developing and marketing high performance reconstructive joint devices and spinal surgical devices . as discussed below , in 2011 we entered into an asset purchase agreement to sell substantially all of our assets in the reconstructive division to arthrex , inc. ( `` arthrex `` ) . additionally , we completed the sale of substantially all of the assets in the spine division in 2011. our continuing operations include the collection and management of our royalty income earned in connection with the asset purchase agreement with arthrex , as well as continuing to promote our former products sold to arthrex through participation in mobile teaching labs , seminars and live surgery and seek a joint venture partner or buyer for the remaining intellectual property owned by the company . the company will also be evaluating future investment opportunities and uses for its cash . we are headquartered in los angeles , california . our common stock is quoted on the national association of securities dealers , inc. 's , over-the-counter bulletin board , or the otc bulletin board with a trading symbol of cdom.ob . critical accounting policies and estimates our significant accounting policies are more fully described in the notes to our consolidated financial statements . those material accounting estimates that we believe are the most critical to an investor 's understanding of our financial results and condition are discussed immediately below and are particularly important to the portrayal of our financial position and results of operations and require the application of significant judgment by our management to determine the appropriate assumptions to be used in the determination of certain estimates . use of estimates financial statements prepared in accordance with united states generally accepted accounting principles ( `` u.s. gaap `` ) require management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period . among other things , management makes estimates relating to allowances for doubtful accounts , net realizable value of assets , share- based payment , and deferred income tax assets . actual results could differ from those estimates . 11 revenue recognition the company 's revenue consists of royalty income from arthrex pursuant to the arthrex asset purchase agreement . royalty income is recognized as the amount becomes known and collectability is reasonably assured . income taxes deferred income tax assets and liabilities are recognized to reflect the estimated future tax effects , calculated at currently effective tax rates , of future deductible or taxable amounts attributable to events that have been recognized on a cumulative basis in the financial statements . a valuation allowance related to a deferred income tax asset is recorded when it is more likely than not that some portion of the deferred income tax asset will not be realized . deferred income tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates on the date of enactment . the company recognizes all material tax positions , including all significant uncertain tax positions , in which it is more likely than not that the position will be sustained based on its technical merits and if challenged by the relevant taxing authorities . at each balance sheet date , unresolved uncertain tax positions are reassessed to determine whether subsequent developments require a change in the amount of recognized tax benefit . recent accounting pronouncements in may 2014 , the financial accounting standards board ( `` fasb `` ) issued accounting standards update ( `` asu `` ) 2014-09 , revenue from contracts with customers ( topic 606 ) . asu 2014-09 creates a new topic in the asc topic 606 and establishes a new control-based revenue recognition model , changes the basis for deciding when revenue is recognized over time or at a point in time , provides new and more detailed guidance on specific topics , and expands and improves disclosures about revenue . in addition , asu 2014-09 adds a new subtopic to the codification , asc 340-40 , other assets and deferred costs : contracts with customers , to provide guidance on costs related to obtaining a contract with a customer and costs incurred in fulfilling a contract with a customer that are not in the scope of another asc topic . the guidance in asu 2014-09 is effective for public entities for annual reporting periods beginning after december 15 , 2016 , including interim periods therein . early application is not permitted . management is in the process of assessing the impact of asu 2014-09 on the company 's financial statements . results of operations and financial condition for the year ended december 31 , 2015 as compared to the year ended december 31 , 2014 the following are the consolidated results of our operations for the year ended december 31 , 2015 compared to the year ended december 31 , 2014. replace_table_token_2_th 12 royalty income royalty income amounted to $ 517,000 for the year ended december 31 , 2015 compared with $ 427,000 for 2014. revenues represented royalties received from arthrex in connection with the arthrex asset purchase agreement . the increase during 2015 is the result of arthrex 's increased sales of the acquired product line . until we find a joint venture partner or buyer for our remaining intellectual property

